Fri, February 12, 2021

David Lebovitz Maintained (ALNY) at Buy with Increased Target to $206 on, Feb 12th, 2021

David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $203 to $206 on, Feb 12th, 2021.

David has made no other calls on ALNY in the last 4 months.



There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, all agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Do Kim of "BMO Capital" Downgraded from Buy to Hold and Held Target at $185 on, Monday, January 25th, 2021
  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $93 on, Wednesday, November 25th, 2020